At a glance
ClinicalIndex Comparison RecordN/ACompleted· 36 enrolled
Drug / intervention
Fermented milk +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Double-blind Controlled Clinical Study of the Antihypertensive Effect of Fermented Milk With Lactococcus Lactis NRRL-B50571
Centro de Investigación en Alimentación y Desarrollo A.C.·interventional·Posted Feb 2, 2016·Updated Oct 12, 2023
In Brief
A clinical study evaluating Fermented milk and Acidified milk for Hypertension. Completed, enrolled 36 participants.
Detailed Summary
The objective of the present work was to evaluate the antihypertensive effect associated with the consumption of fermented milk with Lactococcus lactis NRRL-B50571 on prehypertensive subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
Primary CompletionDec 2013
First PostedFeb 2016
TodayJul 2026
First PostedFeb 2, 2016
Enrollment StartAug 1, 2013
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 10.4 years ago
Interventions
Fermented milkdietary
150 mL daily of fermented milk with Lactococcus lactis NRRL-B50571
Acidified milkdietary
150 mL daily of artificially acidified milk